Publications by authors named "Ohata C"

Cadmium is a contributing factor to cardiovascular diseases and highly toxic to vascular endothelial cells. It has a distinct mode of injury, causing the de-endothelialization of regions in the monolayer structure of endothelial cells in a concentration-dependent manner. However, the specific molecules involved in the cadmium toxicity of endothelial cells remain unclear.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical trials often leave out elderly patients, leading to limited safety and efficacy data for biologics in this demographic.
  • A study comparing elderly (≥65 years) and younger (<65 years) patients using data from the West Japan Psoriasis Registry found that treatment-ending adverse events were more common in the elderly, and malignant neoplasms occurred at higher rates.
  • Despite some safety concerns, biologics were effective for both age groups, with no significant differences in treatment outcomes or quality of life indicators between the elderly and younger patients.
View Article and Find Full Text PDF
Article Synopsis
  • The study explored sex differences in how home blood pressure (HBP) measurements predict cardiovascular events in men and women with hypertension, analyzing data from the HOMED-BP study.
  • Results showed that increases in systolic HBP significantly raised cardiovascular risk in women at both baseline and during treatment, while it did not predict events in men at baseline.
  • Although on-treatment HBP was linked to cardiovascular risk for both sexes, the risk increase was notably higher for women, highlighting the need for better HBP management in women.
View Article and Find Full Text PDF

Introduction: Evidence on treatment effectiveness in patients with psoriasis having anxiety or depressive symptoms helps shared decision-making. This single-arm, open-label, prospective study-ProLOGUE-was conducted to assess the effectiveness of brodalumab on self-assessed anxiety and depressive symptoms in Japanese patients with psoriasis.

Methods: Patients aged ≥ 18 years with plaque psoriasis without peripheral arthritis symptoms who had responded inadequately to current therapies were enrolled at 15 Japanese facilities and received brodalumab 210 mg subcutaneously.

View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed data from 1003 psoriasis patients treated at 20 facilities in Western Japan, focusing on the survival rates of various systemic treatments, including biologics and traditional drugs, from 2010 onward.
  • * Recently released interleukin 17 inhibitors had higher survival rates overall, but the differences were less pronounced for patients starting treatment after 2017; factors like obesity and coexisting psoriatic arthritis were linked to worse drug survival rates, while no significant safety concerns were reported
View Article and Find Full Text PDF
Article Synopsis
  • - A study from the West Japan Psoriasis Registry examined 1847 psoriasis patients and found that 10.8% had a family history of the condition, which correlated with an earlier onset and longer duration of the disease.
  • - Patients with a family history of psoriasis were more likely to develop psoriatic arthritis (PsA), with a higher percentage (34.7%) compared to those without a family history (26.6%).
  • - The research suggests that genetics play a significant role in the development of PsA, indicating that dermatologists should pay closer attention to joint symptoms in patients with psoriasis who have a family history of the disease.
View Article and Find Full Text PDF

Itching and skin pain are bothersome symptoms of psoriasis, but evidence is limited regarding the treatment effectiveness on these symptoms in daily clinical settings. We assessed the changes in the levels of itching and skin pain after brodalumab treatment in Japanese patients with psoriasis using patient-reported outcomes (PROs). Patients with psoriasis who have inadequate response to existing treatments were enrolled in the single-arm, open-label, multicenter, prospective ProLOGUE study and received brodalumab 210 mg subcutaneously in daily clinical practice.

View Article and Find Full Text PDF

We report a mother and an adult son with Darier's disease. The mother, 76 years old and Japanese, had positivity for anti-desmoglein (Dsg)1 antibodies. She had erythema with hyperkeratosis and seborrheic and interstitial blistering.

View Article and Find Full Text PDF

Background: Real-life evidence on the quality of treatment with brodalumab in patients with plaque psoriasis based on patient-reported outcomes remains limited.

Objective: To assess the effectiveness of brodalumab in achieving treatment satisfaction for real-life Japanese patients with psoriasis.

Methods: As part of a single-arm, open-label, multicenter, prospective study (ProLOGUE), Psoriasis Area and Severity Index (PASI) scores, body surface area (BSA), and Treatment Satisfaction Questionnaire for Medication-9 (TSQM-9) domain scores were assessed at baseline and Weeks 12 and 48 of brodalumab treatment.

View Article and Find Full Text PDF

The predictive power of home blood pressure (BP) in the evening compared with home BP in the morning and office BP has been controversial. The predictive power of evening BP was compared to that of morning BP and office BP. The likelihood ratio test between one model containing a single BP index with traditional risk factors and a similar model further containing another BP index was used to assess whether the additional BP index significantly improved the adequacy of the model.

View Article and Find Full Text PDF

Generalized pustular psoriasis (GPP) is a rare and severe subtype of psoriasis. Because of its rarity, GPP studies with a large sample size have been scarce. We studied the characteristics of GPP and pustular psoriasis using data from the West Japan Psoriasis Registry that had been registered until the end of December 2020.

View Article and Find Full Text PDF

A young woman with microscopic polyangiitis (MPA) requiring hemodialysis showed repeated posterior reversible encephalopathy syndrome (PRES) with spatiotemporal multiple lesions over a period of two months. The first PRES episode with confusion and the second PRES episode with vertigo and nausea were caused by MPA, hypertension and renal failure. These symptoms were improved by the reinforcement of MPA treatment and blood pressure management.

View Article and Find Full Text PDF

Background: Plaque psoriasis significantly affects patients' health-related quality of life. To aid treatment decisions, not only objective assessment by physicians but also subjective assessment by patients is important.

Objective: To assess the significance of Dermatology Life Quality Index (DLQI) evaluation at the time of biologics introduction in clinical practice in Japanese patients with plaque psoriasis.

View Article and Find Full Text PDF

A 57-year-old man had a 2-year history of a painful nodule on the right sole. Physical examination revealed an 8 × 8 mm hyperkeratotic plaque with a central fissure. Excisional biopsy disclosed epithelial invagination surrounded by the acanthotic epidermis with parakeratotic hyperkeratosis and focal hypergranulosis.

View Article and Find Full Text PDF

We evaluated the efficacy and safety of interleukin (IL)-17 inhibitors (IL-17i) by analyzing 66 patients with psoriasis treated with secukinumab (n = 25), ixekizumab (n = 17) and brodalumab (n = 24) at Kurume University Hospital between December 2014 and June 2019. The mean Psoriasis Area and Severity Index (PASI) scores at baseline were 12.9, 13.

View Article and Find Full Text PDF

Although rare, tuberculosis has been reported with biologic treatment against psoriasis in Japan, a tuberculosis medium-burden country. Mycobacterial infection often develops after a long incubation period and might not have been adequately identified in clinical trials or post-marketing surveillance. To determine the real-world incidence of tuberculosis in psoriatic patients treated with biologics, we conducted a retrospective, multicenter, observational study in 18 facilities in Western Japan.

View Article and Find Full Text PDF

Cutaneous histiocytic sarcoma (HS) is a rare malignant tumor. An 82-year-old woman presented with a 4 × 2-cm irregular-shaped red nodule on the left posterior scalp. A biopsy specimen revealed sheets of pleomorphic atypical cells in the dermis and subcutis.

View Article and Find Full Text PDF

Sarcomatoid variant of primary cutaneous anaplastic large cell lymphoma is rare and is a diagnostic challenge. Clinical manifestation often mimics that of an infectious disease. Predominance of spindle cells in the biopsy specimen prevents from suspecting lymphoma.

View Article and Find Full Text PDF